VIR-576 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "VIR-576" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

5doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1hivandhepatitis.com

low place

1handle.net

102^nd place

76^th place

1gtt-vih.org

low place

1hepatitiscnewdrugs.blogspot.com.es

low place

1aidsreviews.com

low place

1sld.cu

5,873^rd place

low place

1typepad.com

1,429^th place

932^nd place

1medscape.org

low place

aidsreviews.com

Poveda E (2007). "Discovery of VIRIP--a natural HIV entry inhibitor" (PDF). AIDS Rev. 9 (2): 126. PMID 17694679.

doi.org

Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, Tillmann HC, Barlos K, Busmann A, Canales-Mayordomo A, Giménez-Gallego G, Hirsch J, Jiménez-Barbero J, Meyer-Olson D, Münch J, Pérez-Castells J, Ständker L, Kirchhoff F, Schmidt RE (December 2010). "Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide". Sci Transl Med. 2 (63): 63re3. doi:10.1126/scitranslmed.3001697. hdl:10261/52876. PMID 21178138. S2CID 24783051.
González-Ortega E, Ballana E, Badia R, Clotet B, Esté JA (December 2011). "Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1". Antiviral Res. 92 (3): 479–83. doi:10.1016/j.antiviral.2011.10.010. PMID 22027647.
Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH (November 2008). "Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs". PLOS Pathog. 4 (11): e1000203. doi:10.1371/journal.ppat.1000203. PMC 2577619. PMID 19008954.
Patel IH, Zhang X, Nieforth K, Salgo M, Buss N (2005). "Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide". Clin Pharmacokinet. 44 (2): 175–86. doi:10.2165/00003088-200544020-00003. PMID 15656696. S2CID 2516685.
Gonzalez E, Ballana E, Clotet B, Esté JA (August 2011). "Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP)". AIDS. 25 (13): 1557–83. doi:10.1097/QAD.0b013e328348a733. PMID 21572303. S2CID 44666566.

gtt-vih.org

"El descubrimiento de un inhibidor del VIH en sangre humana apunta a un nuevo tipo de inhibidor de la fusión" [The discovery of an HIV inhibitor in human blood points to a new kind of fusion inhibitor] (in Spanish).

handle.net

hdl.handle.net

Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, Tillmann HC, Barlos K, Busmann A, Canales-Mayordomo A, Giménez-Gallego G, Hirsch J, Jiménez-Barbero J, Meyer-Olson D, Münch J, Pérez-Castells J, Ständker L, Kirchhoff F, Schmidt RE (December 2010). "Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide". Sci Transl Med. 2 (63): 63re3. doi:10.1126/scitranslmed.3001697. hdl:10261/52876. PMID 21178138. S2CID 24783051.

hepatitiscnewdrugs.blogspot.com.es

Kelland K (2010). "VIR-576: Experimental HIV medicine can halt one of the earliest stages of HIV". Reuters.

hivandhepatitis.com

Liz Highleyman (2011). "Novel Entry Inhibitor VIR-576 Shows Promise in Early Study". hivandhepatitis.com.

medscape.org

O'Brien WA (July 31, 2001). "HIV entry—from molecular insights to specific inhibitors". Medscape HIV/AIDS Conference Coverage. Medscape.

nih.gov

pubmed.ncbi.nlm.nih.gov

Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, Tillmann HC, Barlos K, Busmann A, Canales-Mayordomo A, Giménez-Gallego G, Hirsch J, Jiménez-Barbero J, Meyer-Olson D, Münch J, Pérez-Castells J, Ständker L, Kirchhoff F, Schmidt RE (December 2010). "Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide". Sci Transl Med. 2 (63): 63re3. doi:10.1126/scitranslmed.3001697. hdl:10261/52876. PMID 21178138. S2CID 24783051.
Poveda E (2007). "Discovery of VIRIP--a natural HIV entry inhibitor" (PDF). AIDS Rev. 9 (2): 126. PMID 17694679.
González-Ortega E, Ballana E, Badia R, Clotet B, Esté JA (December 2011). "Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1". Antiviral Res. 92 (3): 479–83. doi:10.1016/j.antiviral.2011.10.010. PMID 22027647.
Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH (November 2008). "Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs". PLOS Pathog. 4 (11): e1000203. doi:10.1371/journal.ppat.1000203. PMC 2577619. PMID 19008954.
Patel IH, Zhang X, Nieforth K, Salgo M, Buss N (2005). "Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide". Clin Pharmacokinet. 44 (2): 175–86. doi:10.2165/00003088-200544020-00003. PMID 15656696. S2CID 2516685.
Gonzalez E, Ballana E, Clotet B, Esté JA (August 2011). "Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP)". AIDS. 25 (13): 1557–83. doi:10.1097/QAD.0b013e328348a733. PMID 21572303. S2CID 44666566.

chemdb.niaid.nih.gov

"AIDS#: 472841". NIAID database. U.S. National Institute of Allergy and Infectious Diseases.

pubchem.ncbi.nlm.nih.gov

"[A20]VIRIP - Compound Summary". PubChem.

ncbi.nlm.nih.gov

Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH (November 2008). "Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs". PLOS Pathog. 4 (11): e1000203. doi:10.1371/journal.ppat.1000203. PMC 2577619. PMID 19008954.

semanticscholar.org

api.semanticscholar.org

Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, Tillmann HC, Barlos K, Busmann A, Canales-Mayordomo A, Giménez-Gallego G, Hirsch J, Jiménez-Barbero J, Meyer-Olson D, Münch J, Pérez-Castells J, Ständker L, Kirchhoff F, Schmidt RE (December 2010). "Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide". Sci Transl Med. 2 (63): 63re3. doi:10.1126/scitranslmed.3001697. hdl:10261/52876. PMID 21178138. S2CID 24783051.
Patel IH, Zhang X, Nieforth K, Salgo M, Buss N (2005). "Pharmacokinetics, pharmacodynamics and drug interaction potential of enfuvirtide". Clin Pharmacokinet. 44 (2): 175–86. doi:10.2165/00003088-200544020-00003. PMID 15656696. S2CID 2516685.
Gonzalez E, Ballana E, Clotet B, Esté JA (August 2011). "Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP)". AIDS. 25 (13): 1557–83. doi:10.1097/QAD.0b013e328348a733. PMID 21572303. S2CID 44666566.

sld.cu

boletinaldia.sld.cu

Lic. Aleida Figueroa Silverio (2010). "Diseñan nuevo fármaco capaz de frenar la entrada del VIH en las células" [They design new drug able to slow the entry of HIV into cells] (in Spanish).

typepad.com

tagbasicscienceproject.typepad.com

Jefferys R (2011). "Anchors Away: New HIV Entry Inhibitor Study Creates a Splash". Treatment Action Group (TAG).